nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SHBG—breast cancer	0.287	1	CbGaD
Mitotane—SHBG—Fluoxymesterone—breast cancer	0.238	1	CbGbCtD
Mitotane—Cloperastine—Raloxifene—breast cancer	0.215	1	CrCrCtD
Mitotane—CYP11A1—corpus luteum—breast cancer	0.0127	0.282	CbGeAlD
Mitotane—FDX1—endometrium—breast cancer	0.00216	0.0481	CbGeAlD
Mitotane—FDX1—pituitary gland—breast cancer	0.00196	0.0435	CbGeAlD
Mitotane—FDX1—adipose tissue—breast cancer	0.00195	0.0434	CbGeAlD
Mitotane—FDX1—female reproductive system—breast cancer	0.00179	0.0399	CbGeAlD
Mitotane—FDX1—adrenal gland—breast cancer	0.00175	0.0389	CbGeAlD
Mitotane—FDX1—bone marrow—breast cancer	0.00169	0.0376	CbGeAlD
Mitotane—FDX1—female gonad—breast cancer	0.00163	0.0363	CbGeAlD
Mitotane—FDX1—endocrine gland—breast cancer	0.00152	0.0337	CbGeAlD
Mitotane—CYP11B1—adrenal gland—breast cancer	0.0014	0.0311	CbGeAlD
Mitotane—CYP11B1—endocrine gland—breast cancer	0.00121	0.027	CbGeAlD
Mitotane—FDX1—lymph node—breast cancer	0.00105	0.0233	CbGeAlD
Mitotane—CYP11A1—adipose tissue—breast cancer	0.000885	0.0197	CbGeAlD
Mitotane—SERPINA6—pituitary gland—breast cancer	0.000845	0.0188	CbGeAlD
Mitotane—CYP11A1—female reproductive system—breast cancer	0.000814	0.0181	CbGeAlD
Mitotane—CYP11A1—adrenal gland—breast cancer	0.000794	0.0177	CbGeAlD
Mitotane—SHBG—endometrium—breast cancer	0.000787	0.0175	CbGeAlD
Mitotane—SERPINA6—female reproductive system—breast cancer	0.000774	0.0172	CbGeAlD
Mitotane—SERPINA6—adrenal gland—breast cancer	0.000755	0.0168	CbGeAlD
Mitotane—CYP11A1—female gonad—breast cancer	0.00074	0.0165	CbGeAlD
Mitotane—SERPINA6—bone marrow—breast cancer	0.000731	0.0163	CbGeAlD
Mitotane—SHBG—uterus—breast cancer	0.000725	0.0161	CbGeAlD
Mitotane—SHBG—pituitary gland—breast cancer	0.000712	0.0159	CbGeAlD
Mitotane—SHBG—adipose tissue—breast cancer	0.000709	0.0158	CbGeAlD
Mitotane—Econazole—CYP17A1—breast cancer	0.000702	0.434	CrCbGaD
Mitotane—CYP11A1—endocrine gland—breast cancer	0.000688	0.0153	CbGeAlD
Mitotane—SERPINA6—endocrine gland—breast cancer	0.000655	0.0146	CbGeAlD
Mitotane—SHBG—female reproductive system—breast cancer	0.000652	0.0145	CbGeAlD
Mitotane—SHBG—adrenal gland—breast cancer	0.000636	0.0142	CbGeAlD
Mitotane—SHBG—bone marrow—breast cancer	0.000616	0.0137	CbGeAlD
Mitotane—SHBG—female gonad—breast cancer	0.000593	0.0132	CbGeAlD
Mitotane—SHBG—endocrine gland—breast cancer	0.000552	0.0123	CbGeAlD
Mitotane—CYP11A1—lymph node—breast cancer	0.000476	0.0106	CbGeAlD
Mitotane—Econazole—CYP19A1—breast cancer	0.000357	0.221	CrCbGaD
Mitotane—Econazole—CYP3A4—breast cancer	0.000168	0.104	CrCbGaD
Mitotane—Carbinoxamine—CYP2D6—breast cancer	0.000113	0.0701	CrCbGaD
Mitotane—Carbinoxamine—CYP3A4—breast cancer	9.72e-05	0.0601	CrCbGaD
Mitotane—Chlorphenamine—CYP2D6—breast cancer	9.63e-05	0.0596	CrCbGaD
Mitotane—Chlorphenamine—CYP3A4—breast cancer	8.26e-05	0.0511	CrCbGaD
Mitotane—Tremor—Capecitabine—breast cancer	4.9e-05	0.000352	CcSEcCtD
Mitotane—Neutropenia—Epirubicin—breast cancer	4.89e-05	0.000352	CcSEcCtD
Mitotane—Dizziness—Thiotepa—breast cancer	4.89e-05	0.000351	CcSEcCtD
Mitotane—Rash—Vinorelbine—breast cancer	4.88e-05	0.000351	CcSEcCtD
Mitotane—Dermatitis—Vinorelbine—breast cancer	4.87e-05	0.00035	CcSEcCtD
Mitotane—Hypotension—Paclitaxel—breast cancer	4.86e-05	0.000349	CcSEcCtD
Mitotane—Headache—Vinorelbine—breast cancer	4.85e-05	0.000348	CcSEcCtD
Mitotane—Anaemia—Capecitabine—breast cancer	4.84e-05	0.000348	CcSEcCtD
Mitotane—Body temperature increased—Fluorouracil—breast cancer	4.83e-05	0.000347	CcSEcCtD
Mitotane—Haematuria—Methotrexate—breast cancer	4.75e-05	0.000342	CcSEcCtD
Mitotane—Hepatobiliary disease—Methotrexate—breast cancer	4.71e-05	0.000339	CcSEcCtD
Mitotane—Vertigo—Capecitabine—breast cancer	4.7e-05	0.000338	CcSEcCtD
Mitotane—Hypersensitivity—Mitoxantrone—breast cancer	4.7e-05	0.000338	CcSEcCtD
Mitotane—Hypersensitivity—Irinotecan—breast cancer	4.7e-05	0.000338	CcSEcCtD
Mitotane—Vomiting—Thiotepa—breast cancer	4.7e-05	0.000338	CcSEcCtD
Mitotane—Paraesthesia—Paclitaxel—breast cancer	4.67e-05	0.000336	CcSEcCtD
Mitotane—Hypertension—Docetaxel—breast cancer	4.67e-05	0.000335	CcSEcCtD
Mitotane—Infestation NOS—Epirubicin—breast cancer	4.67e-05	0.000335	CcSEcCtD
Mitotane—Drowsiness—Epirubicin—breast cancer	4.67e-05	0.000335	CcSEcCtD
Mitotane—Infestation—Epirubicin—breast cancer	4.67e-05	0.000335	CcSEcCtD
Mitotane—Rash—Thiotepa—breast cancer	4.66e-05	0.000335	CcSEcCtD
Mitotane—Dermatitis—Thiotepa—breast cancer	4.65e-05	0.000334	CcSEcCtD
Mitotane—Headache—Thiotepa—breast cancer	4.63e-05	0.000333	CcSEcCtD
Mitotane—Somnolence—Paclitaxel—breast cancer	4.63e-05	0.000332	CcSEcCtD
Mitotane—Nausea—Vinorelbine—breast cancer	4.6e-05	0.00033	CcSEcCtD
Mitotane—Dyspepsia—Paclitaxel—breast cancer	4.58e-05	0.000329	CcSEcCtD
Mitotane—Asthenia—Irinotecan—breast cancer	4.58e-05	0.000329	CcSEcCtD
Mitotane—Asthenia—Mitoxantrone—breast cancer	4.58e-05	0.000329	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	4.57e-05	0.000328	CcSEcCtD
Mitotane—Neutropenia—Doxorubicin—breast cancer	4.53e-05	0.000325	CcSEcCtD
Mitotane—Decreased appetite—Paclitaxel—breast cancer	4.52e-05	0.000325	CcSEcCtD
Mitotane—Hypertension—Capecitabine—breast cancer	4.52e-05	0.000325	CcSEcCtD
Mitotane—Hypersensitivity—Fluorouracil—breast cancer	4.5e-05	0.000324	CcSEcCtD
Mitotane—Gastrointestinal disorder—Paclitaxel—breast cancer	4.49e-05	0.000323	CcSEcCtD
Mitotane—Hepatitis—Methotrexate—breast cancer	4.48e-05	0.000322	CcSEcCtD
Mitotane—Asthenia—Gemcitabine—breast cancer	4.46e-05	0.00032	CcSEcCtD
Mitotane—Pain—Paclitaxel—breast cancer	4.45e-05	0.00032	CcSEcCtD
Mitotane—Haematuria—Epirubicin—breast cancer	4.45e-05	0.00032	CcSEcCtD
Mitotane—Confusional state—Docetaxel—breast cancer	4.45e-05	0.00032	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	4.42e-05	0.000318	CcSEcCtD
Mitotane—Urinary tract disorder—Methotrexate—breast cancer	4.42e-05	0.000318	CcSEcCtD
Mitotane—Hepatobiliary disease—Epirubicin—breast cancer	4.41e-05	0.000317	CcSEcCtD
Mitotane—Nausea—Thiotepa—breast cancer	4.39e-05	0.000315	CcSEcCtD
Mitotane—Urethral disorder—Methotrexate—breast cancer	4.39e-05	0.000315	CcSEcCtD
Mitotane—Infection—Docetaxel—breast cancer	4.38e-05	0.000315	CcSEcCtD
Mitotane—Diarrhoea—Mitoxantrone—breast cancer	4.37e-05	0.000314	CcSEcCtD
Mitotane—Diarrhoea—Irinotecan—breast cancer	4.37e-05	0.000314	CcSEcCtD
Mitotane—Shock—Docetaxel—breast cancer	4.34e-05	0.000312	CcSEcCtD
Mitotane—Nervous system disorder—Docetaxel—breast cancer	4.33e-05	0.000311	CcSEcCtD
Mitotane—Thrombocytopenia—Docetaxel—breast cancer	4.32e-05	0.00031	CcSEcCtD
Mitotane—Infestation—Doxorubicin—breast cancer	4.32e-05	0.00031	CcSEcCtD
Mitotane—Drowsiness—Doxorubicin—breast cancer	4.32e-05	0.00031	CcSEcCtD
Mitotane—Infestation NOS—Doxorubicin—breast cancer	4.32e-05	0.00031	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—breast cancer	4.31e-05	0.00031	CcSEcCtD
Mitotane—Confusional state—Capecitabine—breast cancer	4.31e-05	0.000309	CcSEcCtD
Mitotane—Feeling abnormal—Paclitaxel—breast cancer	4.29e-05	0.000308	CcSEcCtD
Mitotane—Skin disorder—Docetaxel—breast cancer	4.28e-05	0.000308	CcSEcCtD
Mitotane—Diarrhoea—Gemcitabine—breast cancer	4.25e-05	0.000306	CcSEcCtD
Mitotane—Infection—Capecitabine—breast cancer	4.24e-05	0.000305	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.22e-05	0.000564	CbGpPWpGaD
Mitotane—Dizziness—Irinotecan—breast cancer	4.22e-05	0.000303	CcSEcCtD
Mitotane—CYP11A1—Metabolism—NDUFS3—breast cancer	4.22e-05	0.000563	CbGpPWpGaD
Mitotane—Anorexia—Docetaxel—breast cancer	4.2e-05	0.000302	CcSEcCtD
Mitotane—Shock—Capecitabine—breast cancer	4.2e-05	0.000302	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	4.19e-05	0.000559	CbGpPWpGaD
Mitotane—Nervous system disorder—Capecitabine—breast cancer	4.19e-05	0.000301	CcSEcCtD
Mitotane—Hepatitis—Epirubicin—breast cancer	4.19e-05	0.000301	CcSEcCtD
Mitotane—Eye disorder—Methotrexate—breast cancer	4.18e-05	0.000301	CcSEcCtD
Mitotane—Diarrhoea—Fluorouracil—breast cancer	4.18e-05	0.0003	CcSEcCtD
Mitotane—Thrombocytopenia—Capecitabine—breast cancer	4.18e-05	0.0003	CcSEcCtD
Mitotane—FDX1—Metabolism—CYP1B1—breast cancer	4.17e-05	0.000557	CbGpPWpGaD
Mitotane—Skin disorder—Capecitabine—breast cancer	4.15e-05	0.000298	CcSEcCtD
Mitotane—Urinary tract disorder—Epirubicin—breast cancer	4.14e-05	0.000297	CcSEcCtD
Mitotane—Hypotension—Docetaxel—breast cancer	4.12e-05	0.000296	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK3—breast cancer	4.12e-05	0.00055	CbGpPWpGaD
Mitotane—Haematuria—Doxorubicin—breast cancer	4.12e-05	0.000296	CcSEcCtD
Mitotane—Connective tissue disorder—Epirubicin—breast cancer	4.12e-05	0.000296	CcSEcCtD
Mitotane—Body temperature increased—Paclitaxel—breast cancer	4.11e-05	0.000296	CcSEcCtD
Mitotane—Urethral disorder—Epirubicin—breast cancer	4.11e-05	0.000295	CcSEcCtD
Mitotane—FDX1—Metabolism—HSP90AA1—breast cancer	4.09e-05	0.000546	CbGpPWpGaD
Mitotane—Hepatobiliary disease—Doxorubicin—breast cancer	4.08e-05	0.000293	CcSEcCtD
Mitotane—Anorexia—Capecitabine—breast cancer	4.07e-05	0.000293	CcSEcCtD
Mitotane—Angiopathy—Methotrexate—breast cancer	4.06e-05	0.000292	CcSEcCtD
Mitotane—Vomiting—Irinotecan—breast cancer	4.06e-05	0.000292	CcSEcCtD
Mitotane—Vomiting—Mitoxantrone—breast cancer	4.06e-05	0.000292	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—MED12—breast cancer	4.06e-05	0.000541	CbGpPWpGaD
Mitotane—Dizziness—Fluorouracil—breast cancer	4.04e-05	0.00029	CcSEcCtD
Mitotane—Visual impairment—Epirubicin—breast cancer	4.04e-05	0.00029	CcSEcCtD
Mitotane—Rash—Irinotecan—breast cancer	4.02e-05	0.000289	CcSEcCtD
Mitotane—Rash—Mitoxantrone—breast cancer	4.02e-05	0.000289	CcSEcCtD
Mitotane—Dermatitis—Mitoxantrone—breast cancer	4.02e-05	0.000289	CcSEcCtD
Mitotane—Dermatitis—Irinotecan—breast cancer	4.02e-05	0.000289	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CDA—breast cancer	4.02e-05	0.000536	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SHMT1—breast cancer	4.02e-05	0.000536	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TGFB1—breast cancer	4e-05	0.000534	CbGpPWpGaD
Mitotane—Headache—Irinotecan—breast cancer	4e-05	0.000287	CcSEcCtD
Mitotane—Headache—Mitoxantrone—breast cancer	4e-05	0.000287	CcSEcCtD
Mitotane—Hypotension—Capecitabine—breast cancer	3.99e-05	0.000287	CcSEcCtD
Mitotane—FDX1—Metabolism—NCOA1—breast cancer	3.98e-05	0.000531	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.97e-05	0.000529	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CHST9—breast cancer	3.97e-05	0.000529	CbGpPWpGaD
Mitotane—Paraesthesia—Docetaxel—breast cancer	3.96e-05	0.000285	CcSEcCtD
Mitotane—Vomiting—Gemcitabine—breast cancer	3.95e-05	0.000284	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.93e-05	0.000524	CbGpPWpGaD
Mitotane—FDX1—Metabolism—STK11—breast cancer	3.93e-05	0.000524	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP19A1—breast cancer	3.93e-05	0.000524	CbGpPWpGaD
Mitotane—Somnolence—Docetaxel—breast cancer	3.92e-05	0.000282	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—breast cancer	3.92e-05	0.000282	CcSEcCtD
Mitotane—Rash—Gemcitabine—breast cancer	3.92e-05	0.000282	CcSEcCtD
Mitotane—Dermatitis—Gemcitabine—breast cancer	3.92e-05	0.000281	CcSEcCtD
Mitotane—Eye disorder—Epirubicin—breast cancer	3.91e-05	0.000281	CcSEcCtD
Mitotane—Malnutrition—Methotrexate—breast cancer	3.9e-05	0.00028	CcSEcCtD
Mitotane—Headache—Gemcitabine—breast cancer	3.89e-05	0.00028	CcSEcCtD
Mitotane—Flushing—Epirubicin—breast cancer	3.89e-05	0.000279	CcSEcCtD
Mitotane—Vomiting—Fluorouracil—breast cancer	3.89e-05	0.000279	CcSEcCtD
Mitotane—Dyspepsia—Docetaxel—breast cancer	3.88e-05	0.000279	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	3.88e-05	0.000517	CbGpPWpGaD
Mitotane—Hepatitis—Doxorubicin—breast cancer	3.88e-05	0.000278	CcSEcCtD
Mitotane—CYP11B1—Metabolism—SLC2A5—breast cancer	3.87e-05	0.000516	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLCO1B1—breast cancer	3.87e-05	0.000516	CbGpPWpGaD
Mitotane—Rash—Fluorouracil—breast cancer	3.85e-05	0.000277	CcSEcCtD
Mitotane—Dermatitis—Fluorouracil—breast cancer	3.85e-05	0.000277	CcSEcCtD
Mitotane—Paraesthesia—Capecitabine—breast cancer	3.84e-05	0.000276	CcSEcCtD
Mitotane—Decreased appetite—Docetaxel—breast cancer	3.83e-05	0.000276	CcSEcCtD
Mitotane—Hypersensitivity—Paclitaxel—breast cancer	3.83e-05	0.000276	CcSEcCtD
Mitotane—Headache—Fluorouracil—breast cancer	3.83e-05	0.000275	CcSEcCtD
Mitotane—Urinary tract disorder—Doxorubicin—breast cancer	3.83e-05	0.000275	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—breast cancer	3.81e-05	0.000274	CcSEcCtD
Mitotane—Gastrointestinal disorder—Docetaxel—breast cancer	3.81e-05	0.000274	CcSEcCtD
Mitotane—Connective tissue disorder—Doxorubicin—breast cancer	3.81e-05	0.000274	CcSEcCtD
Mitotane—Angiopathy—Epirubicin—breast cancer	3.8e-05	0.000273	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—breast cancer	3.8e-05	0.000273	CcSEcCtD
Mitotane—Nausea—Mitoxantrone—breast cancer	3.79e-05	0.000272	CcSEcCtD
Mitotane—Nausea—Irinotecan—breast cancer	3.79e-05	0.000272	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.78e-05	0.000505	CbGpPWpGaD
Mitotane—Pain—Docetaxel—breast cancer	3.77e-05	0.000271	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	3.77e-05	0.000503	CbGpPWpGaD
Mitotane—Dyspepsia—Capecitabine—breast cancer	3.76e-05	0.00027	CcSEcCtD
Mitotane—CYP11A1—Metabolism—COX11—breast cancer	3.76e-05	0.000502	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—APRT—breast cancer	3.74e-05	0.000499	CbGpPWpGaD
Mitotane—Visual impairment—Doxorubicin—breast cancer	3.73e-05	0.000268	CcSEcCtD
Mitotane—Asthenia—Paclitaxel—breast cancer	3.73e-05	0.000268	CcSEcCtD
Mitotane—Decreased appetite—Capecitabine—breast cancer	3.71e-05	0.000267	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	3.7e-05	0.000493	CbGpPWpGaD
Mitotane—Nausea—Gemcitabine—breast cancer	3.69e-05	0.000265	CcSEcCtD
Mitotane—Gastrointestinal disorder—Capecitabine—breast cancer	3.69e-05	0.000265	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.68e-05	0.000492	CbGpPWpGaD
Mitotane—Vision blurred—Methotrexate—breast cancer	3.67e-05	0.000264	CcSEcCtD
Mitotane—Mental disorder—Epirubicin—breast cancer	3.67e-05	0.000264	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.67e-05	0.000489	CbGpPWpGaD
Mitotane—Pain—Capecitabine—breast cancer	3.65e-05	0.000262	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.65e-05	0.000487	CbGpPWpGaD
Mitotane—FDX1—Metabolism—COMT—breast cancer	3.65e-05	0.000487	CbGpPWpGaD
Mitotane—Malnutrition—Epirubicin—breast cancer	3.65e-05	0.000262	CcSEcCtD
Mitotane—Feeling abnormal—Docetaxel—breast cancer	3.64e-05	0.000261	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTP1—breast cancer	3.63e-05	0.000485	CbGpPWpGaD
Mitotane—Nausea—Fluorouracil—breast cancer	3.63e-05	0.000261	CcSEcCtD
Mitotane—Eye disorder—Doxorubicin—breast cancer	3.62e-05	0.00026	CcSEcCtD
Mitotane—Anaemia—Methotrexate—breast cancer	3.6e-05	0.000259	CcSEcCtD
Mitotane—Flushing—Doxorubicin—breast cancer	3.6e-05	0.000258	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	3.59e-05	0.000478	CbGpPWpGaD
Mitotane—FDX1—Metabolism—HMOX1—breast cancer	3.58e-05	0.000478	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ITPR1—breast cancer	3.57e-05	0.000477	CbGpPWpGaD
Mitotane—Dysgeusia—Epirubicin—breast cancer	3.57e-05	0.000257	CcSEcCtD
Mitotane—Diarrhoea—Paclitaxel—breast cancer	3.56e-05	0.000256	CcSEcCtD
Mitotane—Feeling abnormal—Capecitabine—breast cancer	3.52e-05	0.000253	CcSEcCtD
Mitotane—Angiopathy—Doxorubicin—breast cancer	3.52e-05	0.000253	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ESRRA—breast cancer	3.51e-05	0.000469	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ANGPTL4—breast cancer	3.51e-05	0.000469	CbGpPWpGaD
Mitotane—Vertigo—Methotrexate—breast cancer	3.5e-05	0.000252	CcSEcCtD
Mitotane—Body temperature increased—Docetaxel—breast cancer	3.49e-05	0.000251	CcSEcCtD
Mitotane—Dizziness—Paclitaxel—breast cancer	3.44e-05	0.000247	CcSEcCtD
Mitotane—FDX1—Metabolism—ABCB1—breast cancer	3.44e-05	0.000459	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CDA—breast cancer	3.44e-05	0.000459	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SHMT1—breast cancer	3.44e-05	0.000459	CbGpPWpGaD
Mitotane—Vision blurred—Epirubicin—breast cancer	3.44e-05	0.000247	CcSEcCtD
Mitotane—Mental disorder—Doxorubicin—breast cancer	3.39e-05	0.000244	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.39e-05	0.000453	CbGpPWpGaD
Mitotane—FDX1—Metabolism—TYMS—breast cancer	3.38e-05	0.000451	CbGpPWpGaD
Mitotane—Body temperature increased—Capecitabine—breast cancer	3.38e-05	0.000243	CcSEcCtD
Mitotane—Malnutrition—Doxorubicin—breast cancer	3.37e-05	0.000242	CcSEcCtD
Mitotane—Anaemia—Epirubicin—breast cancer	3.37e-05	0.000242	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.36e-05	0.000448	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	3.34e-05	0.000446	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NCOR1—breast cancer	3.34e-05	0.000445	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTM1—breast cancer	3.34e-05	0.000445	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PLA2G4A—breast cancer	3.34e-05	0.000445	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HADHB—breast cancer	3.33e-05	0.000444	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GPI—breast cancer	3.33e-05	0.000444	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC2A5—breast cancer	3.31e-05	0.000442	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLCO1B1—breast cancer	3.31e-05	0.000442	CbGpPWpGaD
Mitotane—Vomiting—Paclitaxel—breast cancer	3.31e-05	0.000238	CcSEcCtD
Mitotane—Dysgeusia—Doxorubicin—breast cancer	3.3e-05	0.000237	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.29e-05	0.000237	CcSEcCtD
Mitotane—Rash—Paclitaxel—breast cancer	3.28e-05	0.000236	CcSEcCtD
Mitotane—Dermatitis—Paclitaxel—breast cancer	3.28e-05	0.000236	CcSEcCtD
Mitotane—Vertigo—Epirubicin—breast cancer	3.28e-05	0.000235	CcSEcCtD
Mitotane—Headache—Paclitaxel—breast cancer	3.26e-05	0.000234	CcSEcCtD
Mitotane—Hypersensitivity—Docetaxel—breast cancer	3.25e-05	0.000234	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—AKT1—breast cancer	3.25e-05	0.000434	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.23e-05	0.000432	CbGpPWpGaD
Mitotane—Confusional state—Methotrexate—breast cancer	3.21e-05	0.00023	CcSEcCtD
Mitotane—CYP11A1—Metabolism—APRT—breast cancer	3.2e-05	0.000426	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GPX1—breast cancer	3.2e-05	0.000426	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	3.19e-05	0.000425	CbGpPWpGaD
Mitotane—Vision blurred—Doxorubicin—breast cancer	3.18e-05	0.000228	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ALDH7A1—breast cancer	3.18e-05	0.000424	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALDH1A1—breast cancer	3.18e-05	0.000424	CbGpPWpGaD
Mitotane—Asthenia—Docetaxel—breast cancer	3.17e-05	0.000227	CcSEcCtD
Mitotane—FDX1—Metabolism—CYP1A1—breast cancer	3.16e-05	0.000422	CbGpPWpGaD
Mitotane—Infection—Methotrexate—breast cancer	3.16e-05	0.000227	CcSEcCtD
Mitotane—Hypertension—Epirubicin—breast cancer	3.15e-05	0.000226	CcSEcCtD
Mitotane—Hypersensitivity—Capecitabine—breast cancer	3.15e-05	0.000226	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	3.14e-05	0.000419	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ERCC2—breast cancer	3.14e-05	0.000419	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.14e-05	0.000419	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.12e-05	0.000417	CbGpPWpGaD
Mitotane—Nervous system disorder—Methotrexate—breast cancer	3.12e-05	0.000224	CcSEcCtD
Mitotane—Anaemia—Doxorubicin—breast cancer	3.12e-05	0.000224	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—breast cancer	3.11e-05	0.000224	CcSEcCtD
Mitotane—Nausea—Paclitaxel—breast cancer	3.09e-05	0.000222	CcSEcCtD
Mitotane—Skin disorder—Methotrexate—breast cancer	3.09e-05	0.000222	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.08e-05	0.000221	CcSEcCtD
Mitotane—Asthenia—Capecitabine—breast cancer	3.06e-05	0.00022	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ADSL—breast cancer	3.05e-05	0.000406	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PHGDH—breast cancer	3.05e-05	0.000406	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NME1—breast cancer	3.05e-05	0.000406	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—FHL2—breast cancer	3.05e-05	0.000406	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—UMPS—breast cancer	3.05e-05	0.000406	CbGpPWpGaD
Mitotane—Vertigo—Doxorubicin—breast cancer	3.03e-05	0.000218	CcSEcCtD
Mitotane—Anorexia—Methotrexate—breast cancer	3.03e-05	0.000218	CcSEcCtD
Mitotane—Diarrhoea—Docetaxel—breast cancer	3.02e-05	0.000217	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ESRRA—breast cancer	3e-05	0.000401	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ANGPTL4—breast cancer	3e-05	0.000401	CbGpPWpGaD
Mitotane—Confusional state—Epirubicin—breast cancer	3e-05	0.000216	CcSEcCtD
Mitotane—CYP11B1—Metabolism—LDHB—breast cancer	2.99e-05	0.000399	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—BRIP1—breast cancer	2.99e-05	0.000399	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HPSE—breast cancer	2.99e-05	0.000399	CbGpPWpGaD
Mitotane—Hypotension—Methotrexate—breast cancer	2.97e-05	0.000213	CcSEcCtD
Mitotane—Infection—Epirubicin—breast cancer	2.96e-05	0.000212	CcSEcCtD
Mitotane—FDX1—Metabolism—MTHFR—breast cancer	2.95e-05	0.000394	CbGpPWpGaD
Mitotane—Shock—Epirubicin—breast cancer	2.93e-05	0.00021	CcSEcCtD
Mitotane—Diarrhoea—Capecitabine—breast cancer	2.92e-05	0.00021	CcSEcCtD
Mitotane—Nervous system disorder—Epirubicin—breast cancer	2.92e-05	0.00021	CcSEcCtD
Mitotane—Dizziness—Docetaxel—breast cancer	2.92e-05	0.00021	CcSEcCtD
Mitotane—Thrombocytopenia—Epirubicin—breast cancer	2.91e-05	0.000209	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—breast cancer	2.91e-05	0.000209	CcSEcCtD
Mitotane—Skin disorder—Epirubicin—breast cancer	2.89e-05	0.000208	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	2.86e-05	0.000381	CbGpPWpGaD
Mitotane—Paraesthesia—Methotrexate—breast cancer	2.85e-05	0.000205	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.85e-05	0.000205	CcSEcCtD
Mitotane—CYP11A1—Metabolism—HADHB—breast cancer	2.85e-05	0.00038	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GPI—breast cancer	2.85e-05	0.00038	CbGpPWpGaD
Mitotane—Anorexia—Epirubicin—breast cancer	2.84e-05	0.000204	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ABCC1—breast cancer	2.83e-05	0.000378	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HMMR—breast cancer	2.83e-05	0.000378	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA3—breast cancer	2.83e-05	0.000378	CbGpPWpGaD
Mitotane—Somnolence—Methotrexate—breast cancer	2.83e-05	0.000203	CcSEcCtD
Mitotane—Dizziness—Capecitabine—breast cancer	2.82e-05	0.000203	CcSEcCtD
Mitotane—Vomiting—Docetaxel—breast cancer	2.8e-05	0.000202	CcSEcCtD
Mitotane—Dyspepsia—Methotrexate—breast cancer	2.8e-05	0.000201	CcSEcCtD
Mitotane—Rash—Docetaxel—breast cancer	2.78e-05	0.0002	CcSEcCtD
Mitotane—Hypotension—Epirubicin—breast cancer	2.78e-05	0.0002	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—AKT1—breast cancer	2.78e-05	0.000371	CbGpPWpGaD
Mitotane—Dermatitis—Docetaxel—breast cancer	2.78e-05	0.0002	CcSEcCtD
Mitotane—Confusional state—Doxorubicin—breast cancer	2.78e-05	0.000199	CcSEcCtD
Mitotane—Decreased appetite—Methotrexate—breast cancer	2.76e-05	0.000199	CcSEcCtD
Mitotane—Headache—Docetaxel—breast cancer	2.76e-05	0.000199	CcSEcCtD
Mitotane—Gastrointestinal disorder—Methotrexate—breast cancer	2.74e-05	0.000197	CcSEcCtD
Mitotane—CYP11B1—Metabolism—PPARGC1B—breast cancer	2.74e-05	0.000366	CbGpPWpGaD
Mitotane—Infection—Doxorubicin—breast cancer	2.74e-05	0.000197	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.73e-05	0.000364	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CAV1—breast cancer	2.72e-05	0.000363	CbGpPWpGaD
Mitotane—Pain—Methotrexate—breast cancer	2.72e-05	0.000195	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ALDH7A1—breast cancer	2.72e-05	0.000363	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALDH1A1—breast cancer	2.72e-05	0.000363	CbGpPWpGaD
Mitotane—Vomiting—Capecitabine—breast cancer	2.72e-05	0.000195	CcSEcCtD
Mitotane—Shock—Doxorubicin—breast cancer	2.71e-05	0.000195	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—breast cancer	2.7e-05	0.000194	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—breast cancer	2.7e-05	0.000194	CcSEcCtD
Mitotane—Rash—Capecitabine—breast cancer	2.69e-05	0.000194	CcSEcCtD
Mitotane—Dermatitis—Capecitabine—breast cancer	2.69e-05	0.000193	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.69e-05	0.000358	CbGpPWpGaD
Mitotane—Headache—Capecitabine—breast cancer	2.68e-05	0.000192	CcSEcCtD
Mitotane—Skin disorder—Doxorubicin—breast cancer	2.67e-05	0.000192	CcSEcCtD
Mitotane—Paraesthesia—Epirubicin—breast cancer	2.67e-05	0.000192	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.67e-05	0.000356	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.67e-05	0.000356	CbGpPWpGaD
Mitotane—Somnolence—Epirubicin—breast cancer	2.65e-05	0.00019	CcSEcCtD
Mitotane—Anorexia—Doxorubicin—breast cancer	2.62e-05	0.000189	CcSEcCtD
Mitotane—Nausea—Docetaxel—breast cancer	2.62e-05	0.000188	CcSEcCtD
Mitotane—Feeling abnormal—Methotrexate—breast cancer	2.62e-05	0.000188	CcSEcCtD
Mitotane—Dyspepsia—Epirubicin—breast cancer	2.62e-05	0.000188	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ADSL—breast cancer	2.61e-05	0.000348	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—UMPS—breast cancer	2.61e-05	0.000348	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PHGDH—breast cancer	2.61e-05	0.000348	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NME1—breast cancer	2.61e-05	0.000348	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—FHL2—breast cancer	2.61e-05	0.000348	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.6e-05	0.000347	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CA9—breast cancer	2.59e-05	0.000346	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA4—breast cancer	2.59e-05	0.000346	CbGpPWpGaD
Mitotane—Decreased appetite—Epirubicin—breast cancer	2.59e-05	0.000186	CcSEcCtD
Mitotane—Hypotension—Doxorubicin—breast cancer	2.57e-05	0.000185	CcSEcCtD
Mitotane—Gastrointestinal disorder—Epirubicin—breast cancer	2.57e-05	0.000185	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.56e-05	0.000341	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HPSE—breast cancer	2.56e-05	0.000341	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—LDHB—breast cancer	2.56e-05	0.000341	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—BRIP1—breast cancer	2.56e-05	0.000341	CbGpPWpGaD
Mitotane—Pain—Epirubicin—breast cancer	2.54e-05	0.000183	CcSEcCtD
Mitotane—Nausea—Capecitabine—breast cancer	2.54e-05	0.000182	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.53e-05	0.000338	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA2—breast cancer	2.52e-05	0.000337	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GPX2—breast cancer	2.52e-05	0.000337	CbGpPWpGaD
Mitotane—Body temperature increased—Methotrexate—breast cancer	2.51e-05	0.000181	CcSEcCtD
Mitotane—CYP11B1—Metabolism—GPX4—breast cancer	2.49e-05	0.000333	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SULT1A1—breast cancer	2.49e-05	0.000333	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CG—breast cancer	2.48e-05	0.000331	CbGpPWpGaD
Mitotane—Paraesthesia—Doxorubicin—breast cancer	2.47e-05	0.000178	CcSEcCtD
Mitotane—Feeling abnormal—Epirubicin—breast cancer	2.45e-05	0.000176	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—breast cancer	2.45e-05	0.000176	CcSEcCtD
Mitotane—CYP11B1—Metabolism—IDH1—breast cancer	2.43e-05	0.000325	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTA1—breast cancer	2.43e-05	0.000325	CbGpPWpGaD
Mitotane—Dyspepsia—Doxorubicin—breast cancer	2.42e-05	0.000174	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ABCC1—breast cancer	2.42e-05	0.000323	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA3—breast cancer	2.42e-05	0.000323	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HMMR—breast cancer	2.42e-05	0.000323	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NAT2—breast cancer	2.41e-05	0.000321	CbGpPWpGaD
Mitotane—Decreased appetite—Doxorubicin—breast cancer	2.39e-05	0.000172	CcSEcCtD
Mitotane—Gastrointestinal disorder—Doxorubicin—breast cancer	2.38e-05	0.000171	CcSEcCtD
Mitotane—Pain—Doxorubicin—breast cancer	2.35e-05	0.000169	CcSEcCtD
Mitotane—Body temperature increased—Epirubicin—breast cancer	2.35e-05	0.000169	CcSEcCtD
Mitotane—CYP11A1—Metabolism—PPARGC1B—breast cancer	2.35e-05	0.000313	CbGpPWpGaD
Mitotane—Hypersensitivity—Methotrexate—breast cancer	2.34e-05	0.000168	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.28e-05	0.000305	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.28e-05	0.000305	CbGpPWpGaD
Mitotane—Asthenia—Methotrexate—breast cancer	2.28e-05	0.000164	CcSEcCtD
Mitotane—Feeling abnormal—Doxorubicin—breast cancer	2.27e-05	0.000163	CcSEcCtD
Mitotane—CYP11A1—Metabolism—GSTA4—breast cancer	2.22e-05	0.000296	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CA9—breast cancer	2.22e-05	0.000296	CbGpPWpGaD
Mitotane—Hypersensitivity—Epirubicin—breast cancer	2.19e-05	0.000158	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.19e-05	0.000292	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CD—breast cancer	2.18e-05	0.000291	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.18e-05	0.00029	CbGpPWpGaD
Mitotane—Body temperature increased—Doxorubicin—breast cancer	2.18e-05	0.000156	CcSEcCtD
Mitotane—Diarrhoea—Methotrexate—breast cancer	2.18e-05	0.000156	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.17e-05	0.000289	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA2—breast cancer	2.16e-05	0.000288	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GPX2—breast cancer	2.16e-05	0.000288	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ALB—breast cancer	2.15e-05	0.000287	CbGpPWpGaD
Mitotane—Asthenia—Epirubicin—breast cancer	2.13e-05	0.000153	CcSEcCtD
Mitotane—CYP11A1—Metabolism—SULT1A1—breast cancer	2.13e-05	0.000285	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GPX4—breast cancer	2.13e-05	0.000285	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—DPYD—breast cancer	2.11e-05	0.000282	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MED12—breast cancer	2.11e-05	0.000282	CbGpPWpGaD
Mitotane—Dizziness—Methotrexate—breast cancer	2.1e-05	0.000151	CcSEcCtD
Mitotane—CYP11A1—Metabolism—IDH1—breast cancer	2.08e-05	0.000278	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTA1—breast cancer	2.08e-05	0.000278	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALDOA—breast cancer	2.08e-05	0.000277	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NAT2—breast cancer	2.06e-05	0.000275	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NOS3—breast cancer	2.06e-05	0.000275	CbGpPWpGaD
Mitotane—Diarrhoea—Epirubicin—breast cancer	2.04e-05	0.000146	CcSEcCtD
Mitotane—Hypersensitivity—Doxorubicin—breast cancer	2.03e-05	0.000146	CcSEcCtD
Mitotane—Vomiting—Methotrexate—breast cancer	2.02e-05	0.000145	CcSEcCtD
Mitotane—CYP11B1—Metabolism—NCOA3—breast cancer	2.02e-05	0.000269	CbGpPWpGaD
Mitotane—Rash—Methotrexate—breast cancer	2e-05	0.000144	CcSEcCtD
Mitotane—CYP11B1—Metabolism—SLC2A2—breast cancer	2e-05	0.000267	CbGpPWpGaD
Mitotane—Dermatitis—Methotrexate—breast cancer	2e-05	0.000144	CcSEcCtD
Mitotane—Headache—Methotrexate—breast cancer	1.99e-05	0.000143	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.98e-05	0.000265	CbGpPWpGaD
Mitotane—Asthenia—Doxorubicin—breast cancer	1.98e-05	0.000142	CcSEcCtD
Mitotane—Dizziness—Epirubicin—breast cancer	1.97e-05	0.000141	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CPT1A—breast cancer	1.96e-05	0.000262	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTR—breast cancer	1.96e-05	0.000262	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ABCG2—breast cancer	1.96e-05	0.000262	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HPGDS—breast cancer	1.92e-05	0.000257	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HBA1—breast cancer	1.91e-05	0.000255	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CB—breast cancer	1.9e-05	0.000253	CbGpPWpGaD
Mitotane—Vomiting—Epirubicin—breast cancer	1.89e-05	0.000136	CcSEcCtD
Mitotane—Nausea—Methotrexate—breast cancer	1.89e-05	0.000136	CcSEcCtD
Mitotane—Diarrhoea—Doxorubicin—breast cancer	1.88e-05	0.000135	CcSEcCtD
Mitotane—FDX1—Metabolism—PTGS2—breast cancer	1.88e-05	0.000251	CbGpPWpGaD
Mitotane—Rash—Epirubicin—breast cancer	1.88e-05	0.000135	CcSEcCtD
Mitotane—Dermatitis—Epirubicin—breast cancer	1.87e-05	0.000135	CcSEcCtD
Mitotane—CYP11B1—Metabolism—GSTT1—breast cancer	1.87e-05	0.000249	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ACHE—breast cancer	1.87e-05	0.000249	CbGpPWpGaD
Mitotane—Headache—Epirubicin—breast cancer	1.86e-05	0.000134	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.86e-05	0.000248	CbGpPWpGaD
Mitotane—Dizziness—Doxorubicin—breast cancer	1.82e-05	0.000131	CcSEcCtD
Mitotane—CYP11A1—Metabolism—MED12—breast cancer	1.81e-05	0.000241	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—DPYD—breast cancer	1.81e-05	0.000241	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALDOA—breast cancer	1.78e-05	0.000237	CbGpPWpGaD
Mitotane—Nausea—Epirubicin—breast cancer	1.77e-05	0.000127	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CYP17A1—breast cancer	1.77e-05	0.000236	CbGpPWpGaD
Mitotane—Vomiting—Doxorubicin—breast cancer	1.75e-05	0.000126	CcSEcCtD
Mitotane—CYP11B1—Metabolism—PTGS1—breast cancer	1.75e-05	0.000233	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ENO1—breast cancer	1.75e-05	0.000233	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.74e-05	0.000233	CbGpPWpGaD
Mitotane—Rash—Doxorubicin—breast cancer	1.74e-05	0.000125	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—breast cancer	1.73e-05	0.000125	CcSEcCtD
Mitotane—CYP11A1—Metabolism—NCOA3—breast cancer	1.73e-05	0.00023	CbGpPWpGaD
Mitotane—Headache—Doxorubicin—breast cancer	1.72e-05	0.000124	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.72e-05	0.00023	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP2D6—breast cancer	1.72e-05	0.000229	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC2A2—breast cancer	1.71e-05	0.000229	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.7e-05	0.000226	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NCOA2—breast cancer	1.68e-05	0.000225	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTR—breast cancer	1.68e-05	0.000224	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCG2—breast cancer	1.68e-05	0.000224	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CPT1A—breast cancer	1.68e-05	0.000224	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HPGDS—breast cancer	1.65e-05	0.00022	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTEN—breast cancer	1.64e-05	0.000219	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HBA1—breast cancer	1.64e-05	0.000218	CbGpPWpGaD
Mitotane—Nausea—Doxorubicin—breast cancer	1.64e-05	0.000118	CcSEcCtD
Mitotane—CYP11B1—Metabolism—FASN—breast cancer	1.63e-05	0.000218	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—BCHE—breast cancer	1.63e-05	0.000217	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC5A5—breast cancer	1.61e-05	0.000214	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTT1—breast cancer	1.6e-05	0.000213	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ACHE—breast cancer	1.6e-05	0.000213	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NQO1—breast cancer	1.55e-05	0.000207	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC2A1—breast cancer	1.55e-05	0.000207	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.52e-05	0.000203	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP3A4—breast cancer	1.51e-05	0.000202	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP17A1—breast cancer	1.51e-05	0.000202	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.51e-05	0.000201	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ENO1—breast cancer	1.5e-05	0.0002	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGS1—breast cancer	1.5e-05	0.0002	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.49e-05	0.000199	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1B1—breast cancer	1.49e-05	0.000198	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.47e-05	0.000196	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP2D6—breast cancer	1.47e-05	0.000196	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HSP90AA1—breast cancer	1.46e-05	0.000195	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NCOA2—breast cancer	1.44e-05	0.000192	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NCOA1—breast cancer	1.42e-05	0.000189	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—STK11—breast cancer	1.4e-05	0.000187	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP19A1—breast cancer	1.4e-05	0.000187	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—FASN—breast cancer	1.4e-05	0.000186	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—BCHE—breast cancer	1.39e-05	0.000186	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC5A5—breast cancer	1.37e-05	0.000183	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NQO1—breast cancer	1.33e-05	0.000177	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC2A1—breast cancer	1.33e-05	0.000177	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.31e-05	0.000175	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—COMT—breast cancer	1.3e-05	0.000173	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.3e-05	0.000173	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP3A4—breast cancer	1.29e-05	0.000173	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTP1—breast cancer	1.29e-05	0.000173	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.29e-05	0.000172	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HMOX1—breast cancer	1.28e-05	0.00017	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ITPR1—breast cancer	1.27e-05	0.00017	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1B1—breast cancer	1.27e-05	0.00017	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HSP90AA1—breast cancer	1.25e-05	0.000167	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ABCB1—breast cancer	1.22e-05	0.000163	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NCOA1—breast cancer	1.21e-05	0.000162	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TYMS—breast cancer	1.2e-05	0.000161	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP19A1—breast cancer	1.2e-05	0.00016	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—STK11—breast cancer	1.2e-05	0.00016	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NCOR1—breast cancer	1.19e-05	0.000159	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PLA2G4A—breast cancer	1.19e-05	0.000159	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTM1—breast cancer	1.19e-05	0.000159	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CA—breast cancer	1.16e-05	0.000154	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GPX1—breast cancer	1.14e-05	0.000152	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1A1—breast cancer	1.13e-05	0.00015	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.12e-05	0.00015	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ERCC2—breast cancer	1.12e-05	0.000149	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—COMT—breast cancer	1.11e-05	0.000148	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTP1—breast cancer	1.11e-05	0.000148	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HMOX1—breast cancer	1.09e-05	0.000146	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ITPR1—breast cancer	1.09e-05	0.000145	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTHFR—breast cancer	1.05e-05	0.00014	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCB1—breast cancer	1.05e-05	0.00014	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TYMS—breast cancer	1.03e-05	0.000137	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PLA2G4A—breast cancer	1.02e-05	0.000136	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NCOR1—breast cancer	1.02e-05	0.000136	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTM1—breast cancer	1.02e-05	0.000136	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GPX1—breast cancer	9.74e-06	0.00013	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CAV1—breast cancer	9.69e-06	0.000129	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1A1—breast cancer	9.64e-06	0.000129	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ERCC2—breast cancer	9.56e-06	0.000128	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKT1—breast cancer	9.46e-06	0.000126	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.26e-06	0.000124	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTHFR—breast cancer	8.99e-06	0.00012	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CG—breast cancer	8.83e-06	0.000118	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CAV1—breast cancer	8.29e-06	0.000111	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.92e-06	0.000106	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CD—breast cancer	7.76e-06	0.000104	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALB—breast cancer	7.66e-06	0.000102	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CG—breast cancer	7.55e-06	0.000101	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NOS3—breast cancer	7.33e-06	9.78e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CB—breast cancer	6.77e-06	9.03e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTGS2—breast cancer	6.7e-06	8.94e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CD—breast cancer	6.64e-06	8.86e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALB—breast cancer	6.55e-06	8.75e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NOS3—breast cancer	6.27e-06	8.37e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTEN—breast cancer	5.85e-06	7.8e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CB—breast cancer	5.79e-06	7.72e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGS2—breast cancer	5.73e-06	7.65e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTEN—breast cancer	5e-06	6.67e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CA—breast cancer	4.12e-06	5.5e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CA—breast cancer	3.53e-06	4.71e-05	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKT1—breast cancer	3.37e-06	4.5e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKT1—breast cancer	2.88e-06	3.85e-05	CbGpPWpGaD
